Due to its broad roles, not limited to the intestinal health, the AhR is an emerging therapeutic target for the pharmacotherapy of several diseases, including atopic dermatitis, intestinal inflammation or cancer [7,11,29]. The gene discussed is AHR; the disease is cancer.